No inventive step in case of „broken technical chain“

Improved patient compliance to a pharmaceutical formulation cannot be used to establish an overall technical effect if it is the result of a "broken technical chain", namely an alleged chain of technical effects starting with information provided to a patient which is then broken by the patient's mental activities.
(EPO Board of Appeal 4 April, 2022, T 752/19, Ticagrelor, acetylsalicylic acid and a computer program/ INTELLECTUAL PROPERTY ENABLER STOCKHOLM).